Dr. Robert Harrison, the Director of Education and Integrated Technology at ACS International Schools, addresses the potential for enhancing classrooms across the UK through the integration of AI in education.
Shop price inflation in the UK has reduced to its lowest level since November 2021, driven by significant price cuts on big-ticket items like furniture and TVs.
Andy Taylor, the Managing Director of Auxilium Medical Services Ltd, talks about their reliable and efficient decontamination services for NHS hospitals, private hospitals, and dental surgeries.
63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.
Dr Preethi Kesavan, Director of Studies, Head and School of Advanced Technology and Digital Media at London School of Business and Finance Singapore, charts Japan’s approach to ICT R&D and building a resilient society.
Ian Newbury, Business Development Director at BT Wholesale, describes how small cells can support greener and more sustainable technology infrastructure and facilitate a better digital future for everyone.
As the nation prepares for a general election, local authorities find themselves grappling with mounting uncertainty and pressure to make critical decisions regarding their property portfolios.
According to a study by e2e-assure, the UK’s leading Threat Detection & Response provider, 44% of Financial Services organisations say their cyber security providers are underperforming.
Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, explains the challenges in detecting, diagnosing and managing autoimmune conditions.
Richard Hebditch, UK Director of the European Federation for Transport and Environment (Transport & Environment), details what needs to be done to tackle transport emissions in the UK.
Émilie Prouzet, Rapporteur for the EESC opinion on the Long-term competitiveness strategy, states the case to relaunch the European internal market and improve the EU’s long-term competitiveness.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute has demonstrated the ability to trigger low levels of a rare type of neutralising antibodies (bnAbs) in a small group of participants.
